The royalty aggregator’s proposed deals for HilleVax and Lava add to a pattern of “zombie” biotech buyouts this year as the ...

In early corporate news, GSK wins a payout after settlement is reached in the legal action between partner CureVac and BioNTech on Thursday, while Renewables Infrastructure posts a widened interim ...

GSK said it would receive $370 million as part of a U.S. patent settlement between CureVac and BioNTech related to messenger mRNA-based Covid-19 vaccines.

Check out our earnings calendar for this week, as well as our previews and recaps of the more noteworthy reports.

Power plant limits – from Obama-era standards on new fossil plants (2015) to Biden’s 2024 guidelines requiring carbon capture retrofits on coal and gas units. Together, these rules were projected to ...